- Home
- OPT vs THFF Comparison
OPT vs THFF Comparison
Compare OPT & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- THFF
- Stock Information
- Founded
- OPT 1984
- THFF 1984
- Country
- OPT Australia
- THFF United States
- Employees
- OPT N/A
- THFF N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- THFF Major Banks
- Sector
- OPT Health Care
- THFF Finance
- Exchange
- OPT Nasdaq
- THFF Nasdaq
- Market Cap
- OPT 574.0M
- THFF 599.3M
- IPO Year
- OPT 2020
- THFF N/A
- Fundamental
- Price
- OPT $3.90
- THFF $46.44
- Analyst Decision
- OPT Strong Buy
- THFF Hold
- Analyst Count
- OPT 1
- THFF 1
- Target Price
- OPT $12.00
- THFF $45.00
- AVG Volume (30 Days)
- OPT 18.3K
- THFF 46.6K
- Earning Date
- OPT 02-26-2025
- THFF 01-28-2025
- Dividend Yield
- OPT N/A
- THFF 4.39%
- EPS Growth
- OPT N/A
- THFF N/A
- EPS
- OPT N/A
- THFF 3.68
- Revenue
- OPT $261,859.00
- THFF $190,119,000.00
- Revenue This Year
- OPT N/A
- THFF N/A
- Revenue Next Year
- OPT $46,864.26
- THFF $11.50
- P/E Ratio
- OPT N/A
- THFF $12.61
- Revenue Growth
- OPT N/A
- THFF N/A
- 52 Week Low
- OPT $1.79
- THFF $34.58
- 52 Week High
- OPT $5.45
- THFF $51.87
- Technical
- Relative Strength Index (RSI)
- OPT 56.41
- THFF 50.43
- Support Level
- OPT $3.59
- THFF $42.65
- Resistance Level
- OPT $3.90
- THFF $46.74
- Average True Range (ATR)
- OPT 0.24
- THFF 1.12
- MACD
- OPT 0.02
- THFF 0.14
- Stochastic Oscillator
- OPT 74.11
- THFF 80.81
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.